Bleakley Financial Group LLC Sells 9,233 Shares of Waldencast plc (NASDAQ:WALD)

Bleakley Financial Group LLC decreased its holdings in Waldencast plc (NASDAQ:WALD) by 35.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,064 shares of the company’s stock after selling 9,233 shares during the period. Bleakley Financial Group LLC’s holdings in Waldencast were worth $69,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. lifted its position in Waldencast by 293.9% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 6,854 shares of the company’s stock worth $25,000 after buying an additional 5,114 shares during the last quarter. SG Americas Securities LLC purchased a new position in shares of Waldencast during the fourth quarter valued at approximately $42,000. Catalina Capital Group LLC bought a new position in shares of Waldencast during the third quarter valued at approximately $58,000. McAdam LLC bought a new stake in shares of Waldencast during the 3rd quarter worth approximately $62,000. Finally, Cubist Systematic Strategies LLC purchased a new position in Waldencast during the 2nd quarter valued at $85,000. 41.97% of the stock is owned by institutional investors.

Waldencast Stock Performance

WALD opened at $3.37 on Thursday. The firm’s 50-day moving average price is $3.48 and its 200-day moving average price is $3.42. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.78 and a current ratio of 1.47. Waldencast plc has a 52-week low of $2.40 and a 52-week high of $8.35.

Analyst Ratings Changes

WALD has been the subject of a number of recent analyst reports. DA Davidson boosted their target price on shares of Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a research note on Wednesday, December 4th. Telsey Advisory Group reiterated an “outperform” rating and issued a $6.00 price target on shares of Waldencast in a report on Monday, November 18th. Canaccord Genuity Group started coverage on Waldencast in a report on Friday, October 25th. They issued a “buy” rating and a $5.00 target price for the company. TD Cowen initiated coverage on shares of Waldencast in a research note on Monday, December 16th. They issued a “hold” rating and a $4.30 price objective for the company. Finally, Canaccord Genuity Group lifted their price objective on shares of Waldencast from $5.00 to $6.00 and gave the company a “buy” rating in a report on Friday, November 22nd. One research analyst has rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Waldencast has a consensus rating of “Moderate Buy” and a consensus target price of $5.76.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.